News & Events

News

All categories

Earnings

Press Release

All years

2021

2020

2019

2018

2017

2016

2015

2014

Affimed Reports Second Quarter 2021 Financial Results and Highlights Operational Progress

September 8, 2021

Affimed to Present at Upcoming Investor Conferences

August 26, 2021

Affimed to Report Second Quarter 2021 Financial Results & Corporate Update on September 8, 2021

August 23, 2021

Affimed Announces Publication of Comprehensive Preclinical Data Demonstrating the Therapeutic Potential of AFM24 in EGFR-expressing Tumors

July 30, 2021

Affimed Reports First Quarter 2021 Financial Results and Highlights Operational Progress

July 1, 2021

Affimed to Report First Quarter 2021 Financial Results & Corporate Update July 1, 2021

June 22, 2021

Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board

June 16, 2021

Affimed to Present at the Jefferies Virtual Healthcare Conference 2021

May 26, 2021

Affimed Announces Virtual Annual General Meeting of Shareholders

May 20, 2021

Affimed Announces Publication of Preclinical Data in Clinical Cancer Research Supporting Therapeutic Potential of AFM13 in Combination with Natural Killer Cells

May 13, 2021

Events

All

Scientific

Investors

27Sep

2021 Cantor Fitzgerald Virtual Global Healthcare Conference

September 27 - 30, 2021 (Virtual)
Presenter: Adi Hoess

07Oct

AACR-NCI-EORTC

October 7 - 10, 2021 (virtual)

02Nov

PEGS Europe

November 2 - 4, 2021 (Barcelona, Spain)

Webcasts
More events